266 related articles for article (PubMed ID: 16049383)
1. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
[TBL] [Abstract][Full Text] [Related]
2. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
[TBL] [Abstract][Full Text] [Related]
3. [Value of tumor markers in the cerebrospinal fluid in the diagnosis of meningeal carcinomatosis].
Shi Q; Pu CQ; Wu WP; Huang XS; Yu SY; Tian CL; Huang DH; Zhang JT
Nan Fang Yi Ke Da Xue Xue Bao; 2010 May; 30(5):1192-4. PubMed ID: 20501426
[TBL] [Abstract][Full Text] [Related]
4. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
5. Leptomeningeal carcinomatosis.
Grossman SA; Krabak MJ
Cancer Treat Rev; 1999 Apr; 25(2):103-19. PubMed ID: 10395835
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients.
Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L
Breast Cancer Res Treat; 2006 Aug; 98(3):241-8. PubMed ID: 16670941
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic meningitis.
Chamberlain MC
Oncologist; 2008 Sep; 13(9):967-77. PubMed ID: 18776058
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist].
Rudnicka H; Niwińska A; Gruszfeld A; Pieńkowski T
Neurol Neurochir Pol; 2003; 37(4):811-24. PubMed ID: 14746241
[TBL] [Abstract][Full Text] [Related]
9. Neoplastic meningitis.
Chamberlain MC
Neurologist; 2006 Jul; 12(4):179-87. PubMed ID: 16832237
[TBL] [Abstract][Full Text] [Related]
10. [Four cases of meningeal metastasis originating from breast cancer].
Kashiwagi S; Asano Y; Watanabe M; Morisaki T; Aomatsu N; Nakamura M; Kawajiri H; Takashima T; Onoda N; Ishikawa T; Wakasa K; Hirakawa K
Gan To Kagaku Ryoho; 2012 Nov; 39(12):1917-9. PubMed ID: 23267929
[TBL] [Abstract][Full Text] [Related]
11. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
[TBL] [Abstract][Full Text] [Related]
13. The value of serial cerebrospinal fluid 14-3-3 protein levels in adult community-acquired bacterial meningitis.
Lu CH; Chang WN; Chang HW; Chung KJ; Tsai HC; Wang HC; Chen SS; Chuang YC; Huang CR; Tsai NW; Chiang YF
QJM; 2008 Mar; 101(3):225-30. PubMed ID: 18234734
[TBL] [Abstract][Full Text] [Related]
14. [Carcinomatous meningitis from prostate cancer diagnosed by cerebrospinal fluid cytology and magnetic resonance image: a case report and review of the literature].
Yasufuku T; Shigemura K; Tanaka H; Matsumoto O; Nakano Y; Tanaka K; Fujisawa M
Hinyokika Kiyo; 2009 Jun; 55(6):361-5. PubMed ID: 19588872
[TBL] [Abstract][Full Text] [Related]
15. [Carcinomatous meningitis presenting with isolated headache].
Outteryck O; Berteloot D; Senechal O; Fromentin C; Mounier-Vehier F
Rev Neurol (Paris); 2004 Oct; 160(10):949-51. PubMed ID: 15492724
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
[TBL] [Abstract][Full Text] [Related]
17. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
[TBL] [Abstract][Full Text] [Related]
19. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
Margel D; Tal R; Baniel J
J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
[TBL] [Abstract][Full Text] [Related]
20. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
